 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || conbercept eye drop (KH906) / Chengdu Kanghong Pharma, Lumitin (conbercept) / Chengdu Kanghong Pharma
New P1 trial: An Exploratory Clinical Trial Evaluating the Tolerability and Efficacy of KH906 in Patients With Corneal Neovascularization (clinicaltrials.gov) - Jan 2, 2020
P1, N=39, Recruiting, Sponsor: Chengdu Kanghong Biotech Co., Ltd.